ImmuneOnco Biopharma

About:

ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.

Website: http://immuneonco.com/

Top Investors: Lilly Asia Ventures, LYFE Capital, Greater Bay Area Homeland Development Fund, Lapam Capital, Shanghai International Group (SIG)

Description:

ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.